Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

approved   save search

RINVOQ® (Upadacitinib) Receives Its Sixth U.S. FDA Approval
Published: 2022-10-21 (Crawled : 21:00) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

rinvoq fda approval
LANNETT RECEIVES FDA APPROVAL TO MANUFACTURE NUMBRINO® AT SEYMOUR PLANT
Published: 2022-10-21 (Crawled : 11:00) - prnewswire.com
LCI | $0.6855 0.0% 19K twitter stocktwits trandingview |
Health Technology
| | O: 15.0% H: 1.09% C: -11.22%

numbrino fda approval
Sienna Receives Government Approval for up to 4 Additional Holes on the Blue Clay Lithium Project in Clayton Valley, Nevada
Published: 2022-10-21 (Crawled : 07:00) - siennaresources.com
SNNAF | $0.0256 262.5% 27K twitter stocktwits trandingview |
Non-Energy Minerals
| | O: 27.41% H: 2.52% C: -8.47%

lithium approval blue
Abiomed Successfully Completes All Impella Post-Approval Studies for High-Risk PCI, Cardiogenic Shock, Post-Cardiotomy Cardiogenic Shock and Right Heart Failure
Published: 2022-10-20 (Crawled : 19:00) - biospace.com/
ABMD | $381.02 0.06% 0.07% twitter stocktwits trandingview |
Health Technology
| | O: 0.22% H: 0.81% C: -0.5%

heart
Oak Valley Community Bank Receives Approval on $27,500 Grant Submitted to Support Jessica’s House in Turlock
Published: 2022-10-19 (Crawled : 21:00) - globenewswire.com
OVLY | News | $24.1 3.52% 3.4% 10K twitter stocktwits trandingview |
Finance
| | O: 1.36% H: 0.0% C: 0.0%

grant oak approval house
Canon Colorado 1650 UVgel Ink Approved for 3M™ MCS™ Warranty program
Published: 2022-10-19 (Crawled : 16:00) - prnewswire.com
CAJ | $21.63 -0.37% 0 twitter stocktwits trandingview |
Electronic Technology
| | O: -0.81% H: 0.55% C: 0.0%

program approved
LMF Acquisition Opportunities, Inc. Stockholders Approve Previously Announced Business Combination with SeaStar Medical, Inc.
Published: 2022-10-18 (Crawled : 23:00) - globenewswire.com
LMAO | $12.35 3.89% twitter stocktwits trandingview |
| | O: 19.67% H: 26.73% C: 3.17%
LMFA | $2.79 4.49% 4.3% 70K twitter stocktwits trandingview |
Commercial Services
| | O: 2.05% H: 16.3% C: -1.09%

acquisition
Lincoln Electric Board Approves 14.3% Dividend Increase
Published: 2022-10-18 (Crawled : 21:00) - globenewswire.com
LECO | $238.06 -0.36% -0.37% 210K twitter stocktwits trandingview |
Producer Manufacturing
| | O: 0.18% H: 0.41% C: -0.03%


Acutus Medical Announces Submission of Premarket Approval Application for AcQBlate Force Sensing Ablation Catheter & System
Published: 2022-10-18 (Crawled : 14:00) - globenewswire.com
AFIB | $0.167 -4.3% -4.49% 400K twitter stocktwits trandingview |
Health Technology
| | O: 4.99% H: 3.06% C: 0.02%

system application approval acqblate submission
ImmixBio Approves 4 Additional Clinical Trial Sites for IMX-110 Clinical Trials, Complementing Existing Soft Tissue Sarcoma Lead Site
Published: 2022-10-18 (Crawled : 14:00) - biospace.com/
IMMX | $2.21 0.0% 64K twitter stocktwits trandingview |
| | O: -6.67% H: 10.71% C: 6.25%

imx-110 trial soft tissue
Viasat and Inmarsat Receive Approval for Proposed Combination from Australia's Foreign Investment Review Board
Published: 2022-10-18 (Crawled : 12:20) - prnewswire.com
VSAT | $15.83 1.93% 1.9% 990K twitter stocktwits trandingview |
Electronic Technology
| | O: 2.68% H: 2.12% C: 1.23%

approval review
Medtronic First to Receive FDA Approval for Pacing the Heart's Natural Conduction System
Published: 2022-10-17 (Crawled : 14:00) - biospace.com/
MDT | $79.48 0.37% -0.29% 6.7M twitter stocktwits trandingview |
Health Technology
| | O: 1.46% H: 0.94% C: -0.05%

fda system approval
Amryt Receives Reimbursement Approval from the Dutch Ministry of Health for Myalepta® (metreleptin)
Published: 2022-10-17 (Crawled : 12:20) - biospace.com/
AMYT | $14.7 0.0% 2.4M twitter stocktwits trandingview |
Health Technology
| | O: -0.15% H: 4.05% C: 2.56%

myalepta health approval
Alvotech’s Partner Submits Application for Marketing Approval of First Biosimilar Candidate in Japan
Published: 2022-10-17 (Crawled : 10:00) - globenewswire.com
ALVO | News | $13.23 2.64% 2.57% 1.7M twitter stocktwits trandingview |
n/a
| | O: 0.44% H: 7.05% C: 2.64%
KMDA | News | $5.05 -0.98% -0.99% 27K twitter stocktwits trandingview |
Health Technology
| | O: 2.74% H: 0.89% C: 0.0%

candidate biosimilar japan application approval
CHMP Recommends Approval of Atara Biotherapeutics’ Ebvallo™ (tabelecleucel) for the Treatment of Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease
Published: 2022-10-14 (Crawled : 15:20) - biospace.com/
ATRA | $0.6755 -2.34% -2.4% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 3.76% H: 0.47% C: -9.9%

treatment disease chmp approval
Libtayo® (cemiplimab) Receives Positive CHMP Opinion Recommending Approval to Treat Advanced Cervical Cancer
Published: 2022-10-14 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
| | O: 6.95% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: 2.74% H: 0.0% C: 0.0%
REGN | $896.27 0.26% 0.25% 500K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 1.13% C: -2.19%

libtayo chmp approval positive cancer
Takeda Receives Positive CHMP Opinion Recommending Approval of Dengue Vaccine Candidate in EU and Dengue-Endemic Countries
Published: 2022-10-14 (Crawled : 15:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.62% H: 0.69% C: -0.69%

candidate chmp vaccine dengue approval positive tak-003 qdengue
LEADING EDGE MATERIALS APPROVES CONTRACTOR TO OPEN BIHOR SUD ADITS
Published: 2022-10-13 (Crawled : 17:00) - globenewswire.com
LEMIF | $0.0755 35.37% 4.1K twitter stocktwits trandingview |
Non-Energy Minerals
| | O: 3.72% H: 0.0% C: 0.0%


ObsEva Announces IND Approval for Yuyuan Bioscience’s Phase 1 Clinical Trial of Nolasiban in China
Published: 2022-10-13 (Crawled : 15:00) - biospace.com/
OBSV | $0.1018 -15.52% -18.95% 8.2M twitter stocktwits trandingview |
Health Technology
| | O: 2.7% H: 0.0% C: 0.0%

trial approval china phase 1
LIXTE BIOTECHNOLOGY ANNOUNCES APPROVAL OF A PHASE 1B/2 RANDOMIZED TRIAL OF DOXORUBICIN +/-LB-100 IN ADVANCED SOFT TISSUE SARCOMAS TO BE CONDUCTED BY THE SPANISH SARCOMA GROUP
Published: 2022-10-13 (Crawled : 14:00) - biospace.com/
LIXT | $3.351 4.68% 11K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 2.88% C: -1.42%

lb-100 trial approval group doxorubicin soft tissue phase 2b
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.